LORRAIN DANIEL S.

PrivateCIK: 1861550
Location

SAN DIEGO, CA

LORRAIN DANIEL S. (Chief Scientific Officer) sold 21.6% of their position (37.18K shares) of CONTINEUM THERAPEUTICS, INC. on the open market

Open‑market sale worth $594.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 3 sales
InsiderLORRAIN DANIEL S.CIK 1861550
Officer· Chief Scientific Officer
Since Mar 2026
-37.18K
Net shares
Net seller
$594.6K
Total sold
3
Open market trades
0B · 3S
7
Total transactions
33.01K acquired · 70.19K disposed
Non-Derivative Transactions5

Class A Common Stock

Direct
M · Option Exercise

Shares

+28.83K

Price / share

$1.01

Trade value

$29.11K

% of position

20.7%
6/30/2026
139.37K168.20K

Class A Common Stock

Direct
S · Sale

Shares

28.83K

Price / share

$16.04

Trade value

$462.29K

% of position

17.1%
6/30/2026
168.20K139.37K

Class A Common Stock

Direct
M · Option Exercise

Shares

+4.18K

Price / share

$1.01

Trade value

$4.22K

% of position

3.0%
7/1/2026
139.37K143.56K

Class A Common Stock

Direct
S · Sale

Shares

5.85K

Price / share

$15.67

Trade value

$91.68K

% of position

4.1%
7/1/2026
143.56K137.70K

Class A Common Stock

Direct
S · Sale

Shares

2.50K

Price / share

$16.24

Trade value

$40.61K

% of position

1.8%
7/1/2026
137.70K135.20K
Total

Net shares

4.17K

Net value

-$561.24K

Derivative Transactions2

Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Class A Common Stock

28.83K shares

Shares

28.83K

Strike price

1.01

Held after

38.48K

Exercisable

6/30/2026

Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Class A Common Stock

4.18K shares

Shares

4.18K

Strike price

1.01

Held after

34.30K

Exercisable

7/1/2026
Non-Derivative Holdings (Post-Transaction)1

Class A Common Stock

Indirect
Shares owned10.11K
Total
10.11K indirect10.11K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported